Carbamazepine responsive dysphagia—A variant of paroxysmal kinesigenic dyskinesia?

Authors

  • Hrishikesh Kumar MD, DM,

    Corresponding author
    1. Movement Disorders Program, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada
    • Movement Disorders Program, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada

    Search for more papers by this author
  • Angela South MA,

    1. Movement Disorders Program, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada
    Search for more papers by this author
  • Mandar Jog MD, FRCPC

    1. Movement Disorders Program, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada
    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: Nothing to report. Mandar Jog served on scientific advisory boards for Allergan (Chair 2008, 2009), Novartis (participant 2008, 2009), Biovail (participant 2009) and Teva (Chair/participant 2008, 2009). He has received travel grants for conference proceedings: Teva 2008; 2009 and Novartis 2009 and also received honoraria from Novartis, Allergan, Biovail Pharma, and Teva Neuroscience, Merz pharmaceutical, Boehringer Ingelheim, Prestwick pharmaceuticals, and GlaxoSmithKline. Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary